AMLX

Amylyx Pharmaceuticals, Inc. Common Stock

$14.07 -1.95%

Recent alerts on AMLX

All signals →

Insider trade Purchase by Firestone Karen

News Why Amylyx Pharmaceuticals Stock Was So Healthy This Week

SEC filing AMLX Reports $1.2B Cash Runway Through 2028, Avexitide Phase 3 LUCIDITY Topline Q3 2026, AMX0114 LUMINA Cohort 1 Data June ENCALS, IND Enabling AMX0318 2027

SEC filing AMLX Pipeline: $160K PBH Patients, AMX0035 Phase 3 2027, AMX0114 ALS Fast Track, AMX0318 Rare Diseases IND 2027

Insider trade Sale by Gina Mazzariello (Chief Legal Officer)

Insider trade Sale by Camille L Bedrosian (Chief Medical Officer)

Insider trade Sale by Joshua B Cohen (Co-Chief Executive Officer)

Insider trade Sale by Justin B. Klee (Co-Chief Executive Officer)

Insider trade Sale by James M Frates (Chief Financial Officer)

Insider trade Sale by Gina Mazzariello (Chief Legal Officer)

Insider trade Sale by Joshua B Cohen (Co-Chief Executive Officer)

Insider trade Sale by James M Frates (Chief Financial Officer)

Insider trade Sale by Justin B. Klee (Co-Chief Executive Officer)

News Amylyx Nominates AMX0318 as Long-Acting GLP-1 Candidate for Rare Endocrine Disorders

Scanner Unusual volume (z=6.9)

Scanner Unusual volume (z=7.2)

Scanner Unusual volume (z=7.2)

Scanner Unusual volume (z=7.2)

Get push alerts for AMLX

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS